Published in Cancer Weekly, October 2nd, 2007
"The hypothesis is that the xeroderma pigmentosum complementary group D (XPD) 156-22541C-- >A and 751-35931A-- >C polymorphisms are associated with the risk of bladder cancer. In a population-based case-control study, 215...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.